AMIX Autonomix Medical, Inc.

Nasdaq autonomix.com


$ 1.17 $ 0.42 (58.18 %)    

Monday, 17-Nov-2025 15:47:31 EST
QQQ $ 602.34 $ -5.20 (-0.85 %)
DIA $ 466.18 $ -5.48 (-1.16 %)
SPY $ 664.83 $ -6.26 (-0.93 %)
TLT $ 89.11 $ 0.22 (0.25 %)
GLD $ 370.86 $ -4.31 (-1.15 %)
$ 1.15
$ 1.20
$ 1.16 x 3,716
$ 1.17 x 3,850
$ 0.96 - $ 1.55
$ 0.69 - $ 14.06
303,678,947
na
7.92M
$ -0.54
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-12-2025 09-30-2025 10-Q
2 08-13-2025 06-30-2025 10-Q
3 05-29-2025 03-31-2025 10-K
4 02-13-2025 12-31-2024 10-Q
5 11-08-2024 09-30-2024 10-Q
6 08-13-2024 06-30-2024 10-Q
7 05-31-2024 03-31-2024 10-K
8 02-13-2024 12-31-2023 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Autonomix Medical, Inc. (NASDAQ:AMIX) ("Autonomix" or the "Company"), a medical device company dedicated to adv...

Core News & Articles

 With over 120 issued and pending patent applications, Autonomix is building a comprehensive, global IP portfolio in nerve-sens...

Core News & Articles

GLP study marks a key milestone in Autonomix's path to achieve regulatory approvalsCompany remains on track to submit Inves...

Core News & Articles

New longer-term post hoc analysis results of responders (n=6)1 showed long-lasting, durable pain reduction of nearly 66%, or a ...

Core News & Articles

On August 25, 2025, Autonomix Medical, Inc. (the "Company") entered into a purchase agreement, dated as of August 25, 2...

Core News & Articles

Global patent estate encompasses 80 issued patents and 40 pending patent applicationsStrengthens strategic position in a multi-...

Core News & Articles

Autonomix Medical (NASDAQ:AMIX) reported quarterly losses of $(1.07) per share which beat the analyst consensus estimate of $(1...

Core News & Articles

Autonomix Medical, Inc. (NASDAQ:AMIX) ("Autonomix" or the "Company"), a medical device company dedicated to adv...

Core News & Articles

With over 80 issued patents and 40 pending patent applications, Autonomix is building a comprehensive IP portfolio in nerve-sen...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION